Vimarsana
Biggest News Aggregation in the World

Page 32 - Roivant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roivant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roivant Sciences Today - Breaking & Trending Today

'Why has Dept of Defense never passed an audit?': Vivek Ramaswamy's latest salvo against US federal system - Vimarsana News

'Why has Dept of Defense never passed an audit?': Vivek Ramaswamy's latest salvo against US federal system

Vivek Ramaswamy has questioned why the Department of Defense remains the only US federal agency that has never completed or passed an audit.

Reviewing Affimed (NASDAQ:AFMD) & PepGen (NASDAQ:PEPG) - Vimarsana News

Reviewing Affimed (NASDAQ:AFMD) & PepGen (NASDAQ:PEPG)

PepGen (NASDAQ:PEPG – Get Free Report) and Affimed (NASDAQ:AFMD – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends. Insider and Institutional Ownership 71.8% of PepGen shares are […]

12 Best UK Stocks To Buy Now - Insider Monkey - Vimarsana News

12 Best UK Stocks To Buy Now - Insider Monkey

In this piece, we will take a look at the 12 best UK stocks to buy now.

12 Best UK Stocks To Buy Now - Vimarsana News

12 Best UK Stocks To Buy Now

In this piece, we will take a look at the 12 best UK stocks to buy now. If you want to skip our overview of the British economy, the biggest players, and recent trends, then take a look at 5 Best UK Stocks To Buy Now. Britain is one of the most developed countries in […]

Source: yahoo.com
Roivant's $7B Roche deal was a 'moment of opportunity,' CEO says - Vimarsana News

Roivant's $7B Roche deal was a 'moment of opportunity,' CEO says

BioPharma